Postdoc in Immuno-Oncology in Luxembourg Institute of Health – Luxembourg

Summary

The Luxembourg Institute of Health is offering a postdoctoral researcher position in Immuno-Oncology within the Translational Cancer Immunogenomics (TCI) Research Group, led by Dr. Ángel Álvarez-Prado. The group, established in 2025, focuses on understanding how genetic alterations in cancer cells influence the immune microenvironment of brain metastatic tumors, aiming to develop personalized immunotherapies. The role involves working at the intersection of immunology and cancer biology, utilizing preclinical models and human samples with advanced technologies. The position is full-time, temporary, and renewable for up to 5 years, with a preferred start date of January 2027. Applicants must hold a PhD in immuno-oncology, immunology, or oncology, possess hands-on experience in various molecular and cellular techniques, and have certified training in animal experimentation. The application deadline is November 1, 2026.

Key Facts

Department	Department of Cancer Research
Position Type	Postdoc
Discipline	Medical sciences
Research Area	Cancer research
Degree Required	PhD in immuno-oncology, immunology or oncology
Experience	Hands-on experience in biochemistry, molecular biology, cell culture, flow cytometry and immunofluorescence techniques. Experience handling preclinical mouse models of cancer and certified training on animal experimentation and welfare (FELASA or equivalent).
Funding	Not funded by a EU programme
Contract Duration	Temporary, renewable for up to 5 years
Language	English
Deadline	2026-11-01
Employer Address	1A-B, rue Thomas Edison L-1445 Strassen Luxembourg

About the Project

The Translational Cancer Immunogenomics (TCI) Research Group investigates how genetic alterations in cancer cells impact the immune microenvironment of brain metastatic tumors. The long-term objective is to develop novel personalized immunotherapies for cancer patients suffering from brain metastasis. The research combines preclinical cancer models and human samples with state-of-the-art technologies to profile the immune microenvironment of brain metastatic tumors following various therapeutic interventions.

Required Skills

• Ph.D. in immuno-oncology, immunology or oncology
• Hands-on experience in biochemistry
• Hands-on experience in molecular biology
• Hands-on experience in cell culture
• Hands-on experience in flow cytometry
• Hands-on experience in immunofluorescence techniques
• Experience handling preclinical mouse models of cancer
• Certified training on animal experimentation and welfare (FELASA or equivalent)
• Fluent command of English (written and spoken)
• Curiosity
• Rigor
• Perseverance
• Creativity
• Excellent time management
• Sense of priority
• Independence
• Ability to effectively communicate scientific results (oral and written)
• Team player

Who Should Apply

Highly motivated postdoctoral researchers with a PhD in immuno-oncology, immunology, or oncology, who have hands-on experience in biochemistry, molecular biology, cell culture, flow cytometry, and immunofluorescence techniques. Candidates must also have certified training and experience in handling preclinical mouse models of cancer. Those with experience in preclinical mouse models of brain cancer, MRI or X-ray irradiator devices, bioinformatic analyses, R programming, or supervising students are particularly encouraged to apply. The ideal candidate will be curious, rigorous, perseverant, creative, possess excellent time management skills, independence, strong communication abilities, and be a team player with fluent English.

Benefits

• Mentoring by the Principal Investigator
• Opportunities for professional growth
• Direct involvement in research projects
• Participation in national and international collaboration partners

About the Employer

The Luxembourg Institute of Health (LIH) is offering a postdoctoral position within its Department of Cancer Research. The Translational Cancer Immunogenomics (TCI) Research Group, led by Dr. Ángel Álvarez-Prado, was established in 2025 and focuses on understanding the immune microenvironment of brain metastatic tumors to develop personalized immunotherapies.

Frequently Asked Questions

What is the main research focus of the TCI Research Group?

The TCI Research Group focuses on understanding how genetic alterations in cancer cells shape the immune microenvironment of brain metastatic tumors, with the long-term goal of developing novel personalized immunotherapies.

What is the required education level for this position?

A Ph.D. in immuno-oncology, immunology, or oncology is required.

Is experience with animal models necessary?

Yes, experience handling preclinical mouse models of cancer and certified training on animal experimentation and welfare (FELASA or equivalent) is a must.

What is the duration of the contract?

The contract is temporary and renewable for up to 5 years.

When is the application deadline?

The application deadline is November 1, 2026, at 01:00 (Europe/Luxembourg).

Is the job funded by an EU Research Framework Programme?

No, the job is not funded by an EU programme.